Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Sacubitril 49 mg + Valsartan 51 mg tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10x14
Price : ₹690/-
Sacustep 100 Tablet is a fixed-dose combination medication containing Sacubitril and Valsartan, formulated to manage chronic heart failure with reduced ejection fraction (HFrEF). Sacubitril is a neprilysin inhibitor that increases the levels of endogenous natriuretic peptides, which promote vasodilation, sodium excretion, and reduced cardiac remodeling. Valsartan is an angiotensin II receptor blocker (ARB) that helps to relax blood vessels, reduce blood pressure, and decrease the workload on the heart. This dual-action therapy improves the heart's pumping efficiency and reduces the risks of hospitalization and cardiovascular death. Sacustep 100 is considered a key advancement in heart failure management and is typically prescribed in place of an ACE inhibitor or ARB in patients who remain symptomatic despite optimal medical therapy. Clinical trials like PARADIGM-HF have demonstrated superior outcomes with this combination over traditional treatments. The 100 mg strength is generally used as a maintenance dose following titration from lower doses.
Common side effects of Sacustep 100 Tablet include hypotension (low blood pressure), hyperkalemia (increased potassium levels), dizziness, fatigue, and renal dysfunction. Some patients may also experience cough or gastrointestinal discomfort. A rare but serious side effect is angioedema (swelling of the face, lips, or throat), which requires immediate medical attention. Monitoring of blood pressure, kidney function, and electrolytes is recommended during treatment.
Sacustep 100 Tablet is indicated for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adult patients. It is used to reduce the risk of cardiovascular death and hospitalization for heart failure, especially in patients who have not achieved adequate symptom control with standard therapies like ACE inhibitors, ARBs, beta-blockers, and diuretics.
Sacustep 100 Tablet should only be taken under the supervision of a qualified healthcare professional. It must not be used together with ACE inhibitors due to the increased risk of angioedema. If switching from an ACE inhibitor, maintain a washout period of at least 36 hours. This medication is not recommended during pregnancy or breastfeeding and should be avoided in patients with a history of angioedema or severe hepatic impairment. Routine monitoring is essential, and patients should inform their doctor of all other medications being taken to avoid potential interactions. Use caution when driving or operating machinery if dizziness occurs. Always follow the prescribed dosage and do not discontinue the medicine without consulting your physician.
Store Sacustep 100 Tablet in a cool, dry place at a temperature below 30°C. Keep it protected from direct sunlight and moisture. Ensure the medication is kept out of reach of children and pets. Do not use the tablet after its expiry date, and keep it in its original packaging to preserve stability.
Composition : Sacubitril 24 mg + Valsartan 26 mg tablet
Composition : Amlodipine 10 mg Tablet
Composition : Amlodipine 2.5 mg Tablet
Composition : Amlodipine 5 mg Tablet
Composition : Amlodipine 5mg + Atenolol 50mg Tablet
Composition : Amlodipine 5mg + Hydrochlorothiazide 12.5mg Tablet
Composition : Bisoprolol 1.25 MG Tablet
Composition : Bisoprolol 2.5 MG Tablet
Composition : Bisoprolol 5 MG Tablet